Micropaque (Barium Sulfate)

Barium sulfate, the active ingredient in Micropaque, is a contrast agent presented as a barium sulfate suspension for oral and rectal use. It creates a radiopaque coating of the gastrointestinal tract, enabling clear X‑ray visualization during diagnostic imaging procedures such as barium swallow and barium enema studies.

GNH USA supplies Micropaque as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, adhering to stringent quality standards and reliable global distribution.

Micropaque is a diagnostic contrast medium used for imaging of the gastrointestinal tract. - Esophageal disorders: enables visualization of esophageal motility and structural lesions during a barium swallow. - Upper gastrointestinal tract: provides detailed images of the stomach and duodenum for assessment of ulcers, tumors, and anatomy. - Lower gastrointestinal tract: outlines the colon and rectum for detection of polyps, inflammation, strictures, or obstruction. - Post‑surgical evaluation: helps assess anastomoses and surgical sites after gastrointestinal procedures.

Micropaque may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nausea or mild stomach upset. - Abdominal cramping or discomfort. - Constipation or temporary bowel irregularity. - Altered taste sensation during oral administration. - Mild diarrhea. - Transient flatulence.

Serious or Rare Side Effects: - Allergic reaction, including rash, itching, or anaphylaxis. - Aspiration of the suspension leading to pneumonia. - Bowel obstruction or impaction, especially in patients with pre‑existing constipation. - Gastrointestinal perforation, particularly if used in the presence of a suspected perforation. - Severe dehydration from prolonged vomiting or diarrhea. - Rare cases of severe electrolyte imbalance.

Before using Micropaque, consider the following safety measures. - Assess for known hypersensitivity: avoid use in patients with documented barium sulfate allergy. - Evaluate gastrointestinal integrity: contraindicated in suspected perforation, severe obstruction, or active inflammation. - Consider alternative imaging: avoid in patients with severe constipation or ileus that may increase risk of impaction. - Monitor fluid balance: ensure adequate hydration before and after administration to reduce risk of constipation. - Store at ambient temperature: keep below 25°C, protect from moisture and light, retain in original container.

Micropaque may interact with other agents that affect imaging quality or gastrointestinal function.

Major Interactions (Avoid): - Concurrent use of potassium iodide preparations: may interfere with radiographic interpretation. - Co‑administration with antacids containing aluminum or magnesium: can reduce coating effectiveness. - Use with other radiopaque contrast agents: may cause cumulative high attenuation and obscure images.

Moderate Interactions (Monitor Closely): - Concurrent laxatives: may alter transit time and affect image quality. - Use with oral antibiotics that affect gut flora: may change bowel motility and contrast distribution. - Administration with other oral contrast agents for separate studies: schedule appropriately to avoid overlapping effects.